PATENT CLAIM ANALYSIS

Application Number: 15915977
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["530", "363000"]

Abstract:
The present invention relates to variants of a parent albumin, the variants having altered plasma half-life compared with the parent albumin. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.

Claim (Index 9):
The method of  claim 2 , wherein said substitution in Domain I is at the amino acid corresponding to position 111 of the amino acid sequence of SEQ ID NO: 2 and wherein said substitution is an aspartic acid, glycine, histidine, arginine, glutamine, or glutamic acid.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 90.0
- Lexical Diversity: 1.63636
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14385631', '14685112', '13463944', '13640235', '15753947']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.675581856734676
- 35 USC 102 Novelty (BERT): 0.6368618570849081
- Combined Prediction Score: 0.6717098567696992
- Mean Citation Score: 495.875554
- Max Citation Score: 598.4777
- Similarity Product: 554.2983645988106

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test